Skip to main content
Equibles

ALLIANCEBERNSTEIN L.P.

Position in IMVT — Immunovant, Inc.

CIK 1109448 NASHVILLE, TN
Back to IMVT Full portfolio

Position in IMVT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,502,615
+$2,256,831 QoQ
Shares Held
116,860
+29.3% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#60
of 226 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ALLIANCEBERNSTEIN L.P. holds $5,185,395,108 across 257 Biotechnology names. IMVT ranks #71 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,019,315 $1,499,784,339
2 ARGX
Argenx SE
 395,661 $367,082,405
3 GMAB
Genmab A/S
 8,644,877 $237,474,771
4 REGN
Regeneron Pharmaceuticals, Inc.
 292,338 $182,284,436
5 TECH
BIO-TECHNE Corp
 2,002,026 $141,443,136
6 HALO
Halozyme Therapeutics, Inc.
 1,696,538 $132,788,029
7 KYMR
Kymera Therapeutics, Inc.
 981,521 $112,551,013
8 BBIO
BridgeBio Pharma, Inc.
 1,453,504 $108,256,977

All Filings in IMVT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,502,615 116,860
2026-03-31 $2,245,784 90,410
2025-12-31 $2,266,447 89,160
2025-09-30 $1,444,722 89,623
2025-06-30 $1,343,360 83,960
2025-03-31 $1,279,186 74,850
2024-12-31 $1,854,034 74,850
2024-09-30 $2,014,231 70,650
2024-06-30 $1,886,280 71,450
2024-03-31 $2,169,616 67,150
2023-12-31 $3,069,591 72,860
2023-09-30 $2,858,519 74,460
2023-06-30 $1,303,239 68,700
2023-03-31 $888,723 57,300
2022-12-31 $1,432,425 80,700
2022-09-30 $479,880 86,000
2022-06-30 $326,040 83,600
2022-03-31 $441,351 80,100
2021-12-31 $680,748 79,900
2021-09-30 $734,305 84,500
2021-06-30 $977,725 92,500
2021-03-31 $537,340 33,500
2020-12-31 $3,576,815 77,437
2020-09-30 $6,172,853 175,415
2020-06-30 $2,645,846 108,659
2020-03-31 $858,472 55,154